Irving R M, Moffat D A, Maher E R
Department of Otoneurosurgery and Surgery of the Skull Base, Addenbrooke's Hospital, Cambridge, UK.
Clin Otolaryngol Allied Sci. 1995 Feb;20(1):5-11. doi: 10.1111/j.1365-2273.1995.tb00003.x.
Many tumours of the skull base, including schwannomas, paragangliomas, meningiomas and anterior pituitary tumours occur both as sporadic tumours and in clear cut familial syndromes. These cancers' highly penetrant dominantly inherited syndromes have proven to be a rich resource for locating tumour genes, most of which are of the tumour suppressor type. Recently, the gene for type 2 neurofibromatosis (NF2) was isolated by the technique of positional cloning. The NF2 gene has now been demonstrated to be involved in the pathogenesis of both familial and non-familial vestibular schwannomas as well as meningiomas. The presence of inactivating mutations within this gene suggests that it acts as a tumour suppressor and the mechanism has been shown to comply with a 'two hit' mutation model. Hereditary tumours constitute a small proportion of all cases, but evidence from studies of tumours such as vestibular schwannoma and meningioma have shown that their genes are also relevant to the much more common non-familial forms of the same tumour. This paper briefly describes the approach to locating tumour genes, and reviews our current knowledge regarding the chromosomal location and function of genes responsible for familial tumours involving the skull base. The genetic mechanisms of tumourigenesis are discussed as are the prospects for the development of novel forms of diagnosis and treatment.
许多颅底肿瘤,包括神经鞘瘤、副神经节瘤、脑膜瘤和垂体前叶肿瘤,既可以散发性出现,也可以在明确的家族综合征中发生。这些癌症的高外显率显性遗传综合征已被证明是寻找肿瘤基因的丰富资源,其中大多数是肿瘤抑制型基因。最近,通过定位克隆技术分离出了2型神经纤维瘤病(NF2)的基因。现已证明,NF2基因与家族性和非家族性前庭神经鞘瘤以及脑膜瘤的发病机制有关。该基因内失活突变的存在表明它起着肿瘤抑制作用,并且其机制已被证明符合“两次打击”突变模型。遗传性肿瘤在所有病例中占比很小,但对前庭神经鞘瘤和脑膜瘤等肿瘤的研究证据表明,它们的基因也与同一肿瘤更为常见的非家族性形式相关。本文简要描述了寻找肿瘤基因的方法,并综述了我们目前关于涉及颅底的家族性肿瘤相关基因的染色体定位和功能的知识。讨论了肿瘤发生的遗传机制以及新型诊断和治疗方法的发展前景。